MedMira (MIR.V) announced saliva-based swab antigen test Usually not my style to post on other boards, but this could be very interessting for the open-minded THRM investors as well: MedMira (MIR.V) has utilized its patented Rapid Vertical Flow® (RVF®) technology and developed the company’s first rapid antigen test, VYRA CoV-2 Antigen Test (VYRA CoV-2), designed to detect SARS-CoV-2 virus in the swab samples.
VYRA CoV-2 product expands the existing COVID-19 product family and directly addresses the wishes of our customers for an equally fast, reliable, and easy-to-use testing solution. VYRA CoV-2 saliva-based swab test is designed to be non-invasive and user-friendly, making this test more suitable for the home settings. “The successful development of this test opens up a new product line that has been a pioneering step for MedMira,” said Hermes Chan, CEO of MedMira. “With this we offer customers our COVID-19 product bundle that can accommodate various testing needs. For example, the VYRA CoV-2 can used to determine if the person is infected; REVEALCOVID-19™ PLUS [PLUS] tells if anti-SARS-CoV-2 antibodies are present; and our REVEALCOVID-19™ Nab-Y [Nab-Y] neutralizing test can potentially identify if the individual is immune to the virus.”
https://www.globenewswire.com/fr/news-release/2021/03/03/2186098/0/en/Product-and-Regulatory-Update-on-MedMira-s-COVID-19-Product-Family.html
DYODD - Wish you all the best